Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Acquisitions & Divestments: 2012-2025

Historic Change in Acquisitions & Divestments for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to $72.4 million.

  • Enanta Pharmaceuticals' Change in Acquisitions & Divestments rose 158.27% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.9 million, marking a year-over-year decrease of 31.45%. This contributed to the annual value of $262.9 million for FY2025, which is 31.45% down from last year.
  • Enanta Pharmaceuticals' Change in Acquisitions & Divestments amounted to $72.4 million in Q3 2025, which was up 21.30% from $59.7 million recorded in Q2 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Change in Acquisitions & Divestments peaked at $134.5 million during Q4 2023, and registered a low of $26.7 million during Q1 2022.
  • For the 3-year period, Enanta Pharmaceuticals' Change in Acquisitions & Divestments averaged around $79.2 million, with its median value being $72.4 million (2023).
  • In the last 5 years, Enanta Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 210.73% in 2023 and then slumped by 76.51% in 2024.
  • Enanta Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $108.8 million in 2021, then dropped by 4.29% to $104.1 million in 2022, then grew by 29.22% to $134.5 million in 2023, then crashed by 42.28% to $77.6 million in 2024, then surged by 158.27% to $72.4 million in 2025.
  • Its Change in Acquisitions & Divestments was $72.4 million in Q3 2025, compared to $59.7 million in Q2 2025 and $53.2 million in Q1 2025.